Allarity Therapeutics
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
123 E Tarpon Ave, Tarpon Springs, Florid...Phone Number
(401) 426-4664Website
www.allarity.comRevenue
<$5 MillionStock Symbol
ALLRIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Allarity Therapeutics
Allarity Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments. The Company is focused on development of stenoparib, a novel PARP/tankyrase inhibitor for advanced ovarian cancer patients, using its DRP® technology to develop a companion diagnostic that can be used to select those patients expected to derive the greatest clinical benefit from stenoparib. Allarity is headquartered in the U.S., with a research facility in Denmark, and is committed to addressing significant unmet medical needs in cancer treatment.Explore more
Allarity Therapeutics Org Chart
JE
Chief Financial Officer
BP
Chief Operating Officer, Product Development ...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allarity Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Allarity Therapeutics launches new products
Allarity Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Allarity Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Allarity Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Allarity Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Allarity Therapeutics recently announced quarterly report
Check out if Allarity Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Allarity Therapeutics
Recommended Actions
Reach out to Masked Content who joined Allarity Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Allarity Therapeutics
Compare insights from companies similar to Allarity Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Allarity Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Allarity Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Allarity Therapeutics.
Allarity Therapeutics financials insights
Gather financial insights about Allarity Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Private Equity
$20M
2026
Debt
$20M
Allarity Therapeutics Tech Stack
A closer look at the technologies used by Allarity Therapeutics
Most Recent Scoops
Earnings
Earnings, Finance
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Executive Moves, Board of Directors
Allarity Therapeutics News & Media
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast Track designation, in advanced ovarian cancer - Allarity has received a Notice of Allowance for new intellectual property covering its stenoparib-specific DRP® companion diagnostic - Strong financial position maintained with approximately $29.8 million in cash and restricted cash as of March 31, 2026
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Allarity Therapeutics
Sign Up For FreeTo access detailed company insights
Allarity Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments. The Company is focused on development of stenoparib, a novel PARP/tankyrase inhibitor for advanced ovarian cancer patients, using its DRP® technology to develop a companion diagnostic that can be used to select those patie... Read More
